Efficacy and safety of sargramostimt in moderate to severe Crohn's disease: Results of NOVEL 4, a phase III multicenter study

被引：0
|
作者：
Feagan, Brian G.
Anderson, Frank
Radford-smith, Gnaharn L.
Solovyov, Oleg
Zurdel-dillinger, Sabine
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A103 / A103
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of abrilumab (AMG 181/MEDI 7183) therapy for moderate to severe Crohn's disease
    Sandborn, W. J.
    Cyrille, M.
    Hansen, M. Berner
    Feagan, B. G.
    Loftus, E. V., Jr.
    Vermeire, S.
    Cruz, M. L.
    Mo, M.
    Sullivan, B. A.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S22 - S23
  • [22] Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease
    Watanabe, Mamoru
    Hibi, Toshifumi
    Mostafa, Nael M.
    Chao, Jingdong
    Arora, Vipin
    Camez, Anne
    Petersson, Joel
    Thakkar, Roopal
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (11): : 1407 - 1416
  • [23] EFFICACY AND SAFETY OF ABRILUMAB (AMG 181/MEDI 7183) THERAPY FOR MODERATE TO SEVERE CROHN'S DISEASE
    Sandborn, William J.
    Cyrille, Marcoli
    Hansen, Mark Berner
    Feagan, Brian G.
    Loftus, Edward V.
    Vermeire, Severine
    Cruz, Martha L.
    Mo, May
    Sullivan, Barbara A.
    Reinisch, Walter
    GASTROENTEROLOGY, 2017, 152 (05) : S598 - S598
  • [24] Comparing the Efficacy and Safety of Adalimumab and Vedolizumab in Treating Moderate to Severe Crohn's Disease and Ulcerative Colitis
    Merza, Nooraldin
    Nawras, Yusuf
    Saab, Omar
    Dahiya, Dushyant Singh
    Ahmed, Zohaib
    Ranabothu, Meghana
    Boujemaa, Safa
    Hassan, Mona
    Kobeissy, Abdallah
    Lilley, Kirthi
    GASTROENTEROLOGY RESEARCH, 2023, 16 (06) : 289 - 306
  • [25] Efficacy and Safety of Long-Term Mirikizumab Treatment in Patients With Moderate to Severe Crohn's Disease
    Sands, Bruce E.
    D'Haens, Geert R.
    Hisamatsu, Tadakazu
    Jairath, Vipul
    Barnes, Edward
    Pellanda, Paola
    Hozak, Rebecca
    Lin, Zhantao
    Yu, Guanglei
    Protic, Marijana
    Owen, Charles C.
    Fischer, Monika
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1040 - S1041
  • [26] Efficacy of Adalimumab in Moderate-to-Severe Pediatric Crohn's Disease
    Viola, Franca
    Civitelli, Fortunata
    Di Nardo, Giovanni
    Barbato, Maria Beatrice
    Borrelli, Osvaldo
    Oliva, Salvatore
    Conte, Francesca
    Cucchiara, Salvatore
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (10): : 2566 - 2571
  • [27] Efficacy of granulocyte/monocyte apheresis for moderate to severe Crohn's disease
    Eaden, James A.
    Ford, Alexander Charles
    GUT, 2013, 62 (04) : 653 - 653
  • [28] Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study
    Sands, Bruce E.
    Chen, Jingjing
    Feagan, Brian G.
    Penney, Mark
    Rees, William A.
    Danese, Silvio
    Higgins, Peter D. R.
    Newbold, Paul
    Faggioni, Raffaella
    Patra, Kaushik
    Li, Jing
    Klekotka, Paul
    Morehouse, Chris
    Pulkstenis, Erik
    Drappa, Jorn
    van der Merwe, Rene
    Gasser, Robert A., Jr.
    GASTROENTEROLOGY, 2017, 153 (01) : 77 - +
  • [29] Efficacy and Safety of Dose Adjustment and Delayed Response to Ustekinumab in Moderate - Severe Crohn's Disease Patients: Results from the IM-UNITI Maintenance Study
    Sands, Bruce
    Gasink, Chris
    Jacobstein, Doug
    Gao, Long Long
    Johanns, Jewel
    Szapary, Philippe
    Colombel, Jean-Frederic
    Targan, Stephan
    Ghosh, Subrata
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S302 - S303
  • [30] Study of the Effects of Risankizumab in Moderate to Severe Crohn's Disease
    Fang, Yuan
    Li, Jipeng
    Wu, J.
    Zhang, Luxi
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 230 - 235
12345